Baroreceptor Activation Structure for Phase-Synced Blood Pressure Reduction

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing treatments for conditions like hypertension, heart failure, and coronary heart disease related to baroreceptor-mediated physiological processes are inadequate or ineffective in many patients.

Innovation Solution

A method and device for stimulating baroreceptors in arteries by applying varying forces during different phases of the cardiac cycle using a baroreceptor activation device, which includes longitudinal struts and connecting members to stretch the receptors, and optionally altering tissue stiffness or delivering substances/energy to facilitate blood pressure reduction.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If existing drugs and devices are used to treat hypertension and cardiovascular conditions, then treatment coverage is provided, but effectiveness is inadequate for many patients

Engineering Contradiction:
Improvetreatment effectivenessVSAvoidresponse variability among patients
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The device applies dynamic, phase-synchronized forcing to the artery wall that adapts to the cardiac cycle. The baroreceptor activation device delivers different amounts of force during different phases (systole vs diastole) to optimize baroreceptor stimulation effectiveness, making the treatment responsive to physiological variations rather than static

Inventive Principle:
Principle #15Dynamics

Solution Approach 2:

The device concentrates mechanical forcing at specific locations on the artery wall where baroreceptors are present, rather than applying uniform treatment throughout. The connecting members apply force at spaced-apart locations to selectively stimulate baroreceptor regions, creating localized physiological effects

Inventive Principle:
Principle #3Local quality

2Reliability

If a baroreceptor activation device applies force to stretch baroreceptors during blood pressure variations, then blood pressure control is improved, but device complexity increases

Engineering Contradiction:
Improveblood pressure controlVSAvoiddevice structure
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The device utilizes the natural periodicity of the cardiac cycle to deliver mechanical forcing at appropriate phases. By synchronizing the application of force with systolic and diastolic phases, the device achieves effective baroreceptor stimulation without requiring complex active control mechanisms, leveraging the body's own rhythmic physiology

Inventive Principle:
Principle #19Periodic action

Solution Approach 2:

The device structure is divided into multiple connecting members that apply force at spaced-apart locations along the artery. This segmentation allows the complex task of blood pressure control to be distributed across multiple simpler mechanical elements rather than requiring a single complex mechanism

Inventive Principle:
Principle #1Segmentation

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method and device effectively stimulate baroreceptors to reduce systemic blood pressure, providing a novel approach to treat hypertension and related conditions.

Implementation Method 1

applying a first amount of force to a region of a wall of the artery with a baroreceptor activation device implanted in the artery to stretch a baroreceptor in the wall during a first local blood pressure of a cardiac cycle within the artery; and applying a second amount of force to the region of the wall of the artery with the baroreceptor activation device during a second local blood pressure of the cardiac cycle within the artery

Methodology Applied
Scientific EffectMechanical force: Mechanical Force

Implementation Method 2

optionally altering tissue stiffness to modulate blood pressure

Methodology Applied
Scientific EffectTissue stiffness alteration:

Data Source

PatentUS20260108742A1Devices and methods for treating cardiovascular and metabolic disease
Publication Date: 2026.04.23 PIERCE RYAN KENDALL
  • US20260108742A1 patent drawing
  • US20260108742A1 patent drawing
  • US20260108742A1 patent drawing

AI summary

Devices and methods described herein may, among other uses, favorably cause the activation and/or deactivation of vascular baroreceptors in order to achieve a desired impact on a physiological condition, such as baroreflex-regulated conditions, hypertension, hypotension, nervous system disorders, metabolic disorders, cardiovascular disease, heart failure, cardiac arrhythmia, renal disease, respiratory disease, diabetes, and insulin resistance. The devices and methods may be used in concert with each other and/or other treatments, medications, interventions, or behavioral regimens. They may also be used in concert with devices and methods that perform or assist with assessing or measuring a mammal's blood pressure, assessing, measuring, or predicting the impact of the described methods and devices on the patient's condition (including blood pressure), and/or protecting the surrounding anatomy from adverse effects.